Azienda Ospedaliera Di Padova
Clinical trials sponsored by Azienda Ospedaliera Di Padova, explained in plain language.
-
Cancer drug could ease rare nerve disorder
Disease control Recruiting nowThis study tests whether zanubrutinib, a drug used for certain blood cancers, can improve nerve function in people with anti-MAG neuropathy—a rare condition causing numbness, weakness, and balance problems. About 50 adults in Italy will take the drug for 12 months. Researchers wi…
Phase: PHASE2 • Sponsor: Azienda Ospedaliera di Padova • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study explores surgery hope for inoperable pancreatic cancer
Knowledge-focused Recruiting nowThis study looks at patients with locally advanced pancreatic cancer that cannot be removed by surgery at first. After at least 4 months of chemotherapy, if the tumor shrinks enough, doctors may consider surgery. The goal is to see if this approach helps patients live longer and …
Sponsor: Azienda Ospedaliera di Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC